Souichi Yamada

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants

Saya Moriyama, Yu Adachi, Takashi Sato et al. · Immunity · 2021 · 154 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants

Shô Miyamoto, Takeshi Arashiro, Yu Adachi et al. · Med · 2022 · 78 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +11

The ORF37 (UL24) is a neuropathogenicity determinant of equine herpesvirus 1 (EHV-1) in the mouse encephalitis model

Samy Kasem, Mi Htay Htay Yu, Souichi Yamada et al. · Virology · 2010 · 55 citations

Life Sciences, Infectious Diseases, Neurology +14

Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells

Souichi Yamada, Shuetsu Fukushi, Hitomi Kinoshita et al. · BMJ Open Respiratory Research · 2021 · 50 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome

Tomoki Yoshikawa, Satoshi Taniguchi, Hirofumi Kato et al. · PLoS Pathogens · 2021 · 49 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17